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URINARY OESTROGEN LEVELS IN MYOCARDIAL INFARCTION
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Ernest Oppenheimer Heart Research Unit, South African Institute for Medical Research, Johannesburg
It is well known and generally recognized that there is a
marked sex difference in the incidence ofmyocardial infarction
and that coronary thrombosis occurs less frequently in
premenopausal women than it does in men of comparable age.
In the Union of South Africa between 1926 and 1954 the toll
of coronary disease increased from O· 9 %to 19· 6 %for males
and from O' 53 % to 11· 6 %for females. In 1954 the mortality
rate from coronary artery disease was 177· 0 and 74· 3 per
100,000 for males and females respectively.l Smit has also
shown that in the younger age groups relatively more males
than females died of this disease, and that the difference in
mortality rate progressively decreased with the increase in
the age of the group.
An analysis of 1,000 consecutive cases attending the Edin-
burgh Royal Infirmary, all of whom had evidence of myo-
cardial infarction or ischaemia, indicated an incidence 15
times higher in men than in women under the age of 40; an
incidence 7 times higher in men under the age of 50 and only
a 2 : 1 ratio of men to women under the age of 60. Oliver
and Boyd, in view of the above findings, suggested that since
the incidence of coronary artery disease increases after
natural or artificial menopause, the development of the
disease may be accelerated by changes in hormonal balance.!
Hueper3 states that atherosclerosis (as exemplified by
coronary sclerosis) occurs much more commonly in men than
in women, and that the recent increase in the frequency of
coronary artery disease in the USA affected men more than
women.
In England and Wales in 1954, deaths attributed to coro-
nary artery disease were 41,688 males and 23,983 females. The
disparity in sex distribution was most evident in the younger
age groups where the male female ratio was 5-6 : 1 whilst in
in the older age groups 75 years and over, there was a ratio of
less than 2 : 1."
Lee and Thomas5 have shown that in the older age groups
the incidence of acute myocardial infarction in females is
proportionately greater than in males. The incidence in women
rose steadily with age, but was stationary in males from 60 to
80 years of age, when the incidence decreased. These findings
were consistent with the theory that female sex hormones
inhibit the development of atherosclerosis since these hor-
mones decrease progressively with age.
Pell and D'Alonzo' have shown that, of 209 persons
(age range 25-64 years) employed at the Du Pont Company,
who developed myocardial infarction during"a I-year period,
the most striking factor was the difference in sex incidence,
which was 0·2 cases per 1,000 female employees and 2·9
cases per 1,000 male employees. The ages of the 2 female
patients were 60 and 64 years respectively.
Current investigations in many countries show a pronounced
difference between the two sexes in mortality from myocardial
ischaemia in the 40-59 year age groups, males showing a
considerably higher mortality than females.
This sex difference between the incidence and mortality
rates has given rise to much speculation and has led to the
theory that in females some endocrine sex factor may exert a
protecting effect, which may operate until after the menopause,
although to a diminishing degree. Keys' though, in a recent
symposium on arteriosclerosis, in discussing the role played by
non-dietary factors in the aetiology of atherosclerosis, sugges-
ted that even the sex factor may have its limitations. He
showed that in population groups with a relatively Iow,
compared with a high death rate 'from the disease, the sex
ratio tends to become narrower. One of us (I.B.)8 has
inferred from the above that among the South African Bantu,
where the incidence of coronary thrombosis is almost negligi-
ble, the sex difference may well be no longer apparent. We
suggested the possibility that it required a particular environ-
mental (dietary and non-dietary) context, highly promotive of·
mortalitv from coronary artery disease, to 'light up' the sex
factor; the latter not being apparent in a'context which pro-
motes a Iow death rate from the disease.
The above observations are borne out in a recent WHO
report on A Study Group of Atherosclerosis and Ischaemic
Heart Disease. The report states, inter alia, that 'in popula-
tions where ischaemic heart disease is frequent, as in the
USA, the ratio of male to female deaths from ischaemic
heart disease is very high in young persons and diminished
after the menopause, whereas in countries such as Italy and
Portugal the disparity in frequency is smaller'. This report
further states that the mortality from coronary artery disease
in married women in the age group 45-49 years is greater in
those with no children than in thoSe having children.9
One of the reasons why a small number of experienced
cardiologists maintain that at the present time there is no
marked sex bias in the incidence of coronary disease is that the
clinical course of ischaemic heart disease tends to be somewhat
different in the two sexes-in the male the onset and course is
more sudden and dramatic and with a rapidly fatal outcome.
This might account for the fact that recent hospital surveys
in Sweden and the USA (and possibly in South Africa) show
more female patients than might be expected from the mor-
tality statistics of the regions concerned.9
Experimental and clinical evidence suggests that oestrogens
may play an important role in the relative immunity from
coronary artery disease in the premenopausal woman, and
that oestrogen therapy to the atherosclerotic male favourably
alters an abnormal lipoprotein pattern to that of a normal
one. ThtlS, Katz and his co-workers have shown that the
administration of oestrogenically active compounds (orally
or parenterally) to cholesterol-fed cockerels results in an
increase in the ratio of free to total plasma cholesterol, in
enhanced hyperphospholipaemia with a lowering of the
cholesterol phospholipid ratio, and in a reduction in the
alpha-lipoprotein and Sf 20-100 levels and that it prevents
coronary atherogenesis without influencing the formation of
aortal lesions. Katz further quotes work done in his labora-
tories on cockerels in which he shows that the coronary vessels
are practically free of lesions when oestrogens and an athero-
genic diet are administered simultaneously, and that oestrogen
reverses both the lipophage and fibroblastic components of
coronary atherosclerotic plaques. Katz and his co-workers
have also shown that sexually mature chickens, unlike
immature birds but like sexually mature humans, exhibit a
9 0 S.A. MEDICAL JOUR AL 4 October 195
significant sex usceptibility to coronary atherosclerosis.10.14
Barr1 $ has shown that the administration of oestrogen to
men who have survived one or more myocardial infarctions,
results in the restoration to normal of the usually gro s
abnormal lipid disturbances found in atherosclerosis; i.e.,
oestrogen administration results in an increase in alpha-
lipoprotein levels with a corresponding decrea e in the beta
fraction, a reduction in serum-cholesterol levels, and a marked
improvement in the cholesterol-pho pholipid ratio of serum
and beta lipoprotein (Taction. Women, too. who have sur-
vived a myocardial infarction, show similar improvement
when treated with oestrogen. The effects of androgen therapy
on the lipid picture are in the main exactly opposite to the
beneficial effects of oestrogens.
Eilert16 has shown that increased oestrogen levels depress
plasma cholesterol, and Boylel1 ha reported reduction in all
serum lipids, including choles\erol, in humans during long-
term administration of oe trogens.
Wuest et 01. 18 reponed that in oophorectomized patients
coronary sclerosis, decade for decade was of a greater degree
of everity than in a control group and conclude that ovarian
hormones exert at least one of the influences in the develop-
ment of atherosclerosis.
Cooper 19 has shown that under the influence of oestrogens
the lipoprotein pattern as well as the atherogenic index
improved remarkably, whilst Gitman20 bas shown similar
effcts following a single intravenous injection of oestrogen.
Gertler et 01. 21 have shown a paucity of atherosclerosis
in eunuchs and a greater liability of patients with predominant
'maleness' to myocardial infarction whilst Cooper19 has
shown that castrated males, eunuchs and eunuchoids have
lipoprotein patterns similar to those observed in healthy young
females.
It has been shown by Oliver and Boyd22 that changes in
plasma lipids occur during the menstrual cycle. A striking
fall in the plasma cholesterol esters, a less marked decrease
in phospholipids and thus a decrease in the cholesterol-phos-
pholipid ratio, occurred at the time of ovulation and im-
mediately before menstruation, and they suggested that the
point where the plasma cholesterol-phospholipid ratio is
lowest coincides with the phase in the menstrual cycle where
oestrogen activity is maximal. One of us (LE.) has shown
similar findings, namely a decrease in total chole terol due
mainly to a decrease in the esterified fraction and a far smaller
decrease in the serum phospholipid at the mid-menstrual
cycle, i.e. at the time of ovulation. It has also been shown at
this Institute that oestrogen administered in small doses to
male hypercholesterolaemic patient who had had a myo-
cardial infarction re ulted in a lowered cholesterol phospho-
lipid ratio. 23
Oliver and Boyd2 and Steiner et aP4 have also hown that
ethinyl 'oestradiol is effective in improving the abnormal
lipoprotein patterns which occur in clinical coronary artery
disease. Ethinyl oestradiol was the most potent oe trogen in
this respect, although hexestrol and oestradiol produced simi-
lar trends. Oestrone and oestriol failed to produce any
significant alterations in the lipid picture when administered
in doses of equivalent oestrogenic potency.
Boyle2S treated a group of patients suffering from proved
coronary artery disease and ·a group of hypercholesterolaemic
patients uffering from xanthoma to is wbero urn and/or
tendinosum with varying doses of ethinyl oestradiol. This
treatment resulted in a reduction in all serum-lipid levels-
a decrease in the cholesterol-phospholipid ratio, a marked
decrease in the beta lipoprotein levels and an increase in the
alpha level.
From the above review two fact emerge:
I. That a marked sex difference in the incidence of coronary
thrombosis exists.
2. That experimental and clinical observations suggest that
oestrogen administration rapidly reverts abnormal lipid
patterns to relatively normal ones.
A COMPARATlVE STUDY
One of the most commonly recognized factors, in the aetiology
of coronary thombosis to date is the broad interrelationship
between dietary fats, lipid disturbances, and the development
of atherosclerosis. However, ince men and women under
the age of 50 consuming almost identical diets show such
marked differences in the incidence of coronary atherosclero-
sis, it was felt that a comparative tudy on urinary oestrogen
levels in a group of normal male subjeCts and in a similar
group, matched for age, of male patients who had recently
suffered from a coronary occlusion, might be profitable.
We have previously suggested that alterations in the balance
between male and female sex hormones may well be involved
in the observed differences between cholesterol levels in the
South African Bantu and White subjects, and indirectly in the
very low incidence of coronary thrombosis in the former!6,27
We have already shown that total oestrogens as well as the
very active and potent oestradiol fraction is ignificantly higher
in the young male Bantu compared with young White sub-
jects." If oestrogen I~els play a role in the aetiology of
coronary atherogenesis then an entirely different oestrogen
pattern should be found (on comparing oestrogen levels) in a
group of subjects who have recently experienced a myocardial
"infarction when compared with a similar group who clinically
show no evidence of coronary artery disease. Such a com-
parative study forms the basis for this investigation.
We obtained 24-hour specimens of urine from 20 European
males subjects employed at the South Afr:ican Institute for
Medical Research and who were in excellent health. and from
23 European male subjects who were .patients at the
Johannesburg General Hospital. All the latter had been
hospitalized for a recent acute myocardial infarction. This
diagnosis was based in each case on clinical evidence and
confirmed by ECG.
The age ranges and mean ages for the normal group was
44-65 years (mean 55) and for the myocardial infarction
group 42-81 years (mean 57) respectively.
The technique used for estimating total oestrogen, oestra-
diol, oestrone and oestriol was that described by Br:own:!8
and identical with that used by us when we compared urinary
oestrogen levels in normal young male urbanized South
African Bantu and young normal White subjects."
RESULTS
Tables I and 1I show the amounts of total oestrogen, and
the absolute and relative amounts of the 3 fractions oestradiol,
oestrone and oestriol, which we found in 24-hour specimens
of urine from the normal and coronary artery disease subjects
respectively.
The mean total urinary oestrogen value in the normal
European (mean age 55)/vas 14·4 /Lg. as compared with 10·8
/Lg. in the acute myocardial infarction group (mean age 57).
The mean oestradiol value was 2· 1 /Lg. in the healthy sub-
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TABLE I. ANALYSIS OF THE OESTROGEN CONTE 'T OF 24-HOUR SPECIME OF URINE IN NORMAL fUROPfA. MALE UWoCTS ( GE AGE 55)
Total
Age. Oestradiol Oestradial Oestrone Oestrone Oestriol Oestriol Oestrogen
p.g. % p.g. % p.g. % p.g.
45 2·5 18·1 4·9 35'- 6·4 46·4 13·
60 3·3 22·0 8·7 5 ·0 3·0 _0·0 15·0
65 0·8 4· ·4 50·3 7·5 44·9 16·7
52 0·9 6·0 ·1 53·6 6'1 40·4 15·1
.60 3·4 19·1 9·0 50·6 5·4 0·3 17·
48 I ·1 9·3 5·4 45· 5·3 44·9 11·
61 0·5 4·7 3·5 33·0 6·6 62·3 10·6
57 1·6 9'1 11· 3 64·6 4·6 26·3 17·5
57 0·9 . 5·2 3·5 20·5 12·7 74·3 17·l
44 1·0 17·9 3·3 58·9 1·3 23·2 5·6
48 1·7 8·1 12·5 59·2 6·9 32·7 21·1
54 3·5 21 ·3 6·2 37· 6·7 40·9 16·4
47 3·5 21 ·6 7·2 44·4 5·5 34·0 16·2
58 3·8 23·7 4·8 30·0 7·4 46·3 16·0
57 3·0 17·9 6·4 3 ·1 7·4 44·0 16·
52 2·1 13·1 6-4 40·0 7·5 46·9 16·0
53 1·7 14·4 5·2 44·1 4·9 41·5 11·8
59 2·8 28·6 3-4 34·7 3·6 36·7 9·8
65 1·2 18·7 2·8 43·8 2·4 37·5 6·4
58 2·9 17·3 5·7 33·9 8·2 48·8 16·8
Mean: 55 2·1 15·0 6·3 43·8 6·0 11' 2 14·4
TABLE II. ANALYSIS OF THE OESTROGE CONTENT OF 24-HOUR SPECIME S OF URIN< J EUROPEA MALE SlJBJECTS SUFFERING FROM ACu-n:
MYOCARDIAL INFARCTIO (AVERAGE AGE 57)
Total
Age Oestradiol Oestradiol Oestrone Oestrone Oestriol Oestriol Oestrogen
p.g. % p.g. % p.g. % p.g.
48 2·0 26·3 I· 5 19·8 4·1 53·9 7·6
64 2·5 16·6 7·9 52·3 4·7 31·1 15·6
55 0·1 2·2 1·3 28·2 3·2 62·6 4·6
47 0·8 5·1 5·1 32·7 9·7 62·2 15·6
58 0·9 8·4 3·0 28·0 6·8 63·7 10·7
48 0·0 0·0 9·6 82·8 2·0 17·2 11·6
43 1·9 fI'5 ' 4·2 25·5 10·4 63·0 16·5
64 0·3 6·7 1·9 42·2 2·3 51 ·1 4·5
52 0·1 3·7 0·7 25·9 1·9 70·4 2·7
71 0·0 0·0 3·0 30·9 6·7 69·1 9·7
48 0·5 10·2 0·6 12·2 3·8 77·6 4·9
42 1· 2 12,] 5·2 52·5 3·5 35·4 9·9
51 1·7 13·9 6·0 49·2 4·5 36·9 12·2
66 0·4 2·3 6·0 33·3 11·6 64·4 18·0
68 0·0 0·0 2·8 32·6 5·8 67-4 8·6
46 0·2 2·2 2·2 23·7 6·9 74·1 9·3
65 0·0 0·0 4·8 51·6 4·5 48·4 9·3
80 0·0 0·0 2·4 23·1 8·0 76·9 10·4
81 0·0 0·0 1·1 6'4 16·2 93·6 17·3
43 0·2 2·3 3·3 38'4 5·1 59·3 8·6
56 2·2 9·2 6·9 29·0 14·7 61·8 23·8
60 0·0 0·0 3·3 33·0 6·7 67·0 10·0
56 1·9 18'5 4·3 41·7 4·1 39·8 10·3
Mean: 57 0·7 6·5 3·7 34·6 6·4 58·9 10·8
jects as compared with O· 7 p.g. in the patients: whilst the
percentages of oestradiol to total oestrogen were 15 % and
6· 5% respectively.
The mean oestrone value was 6·3 p.g. with a percentage of
43· 8%in the healthy group as against 3· 7 p.g. and 34· 6%in
the myocardial infarction group.
The mean oestriol value was 6 p.g. and 41· 2%in the normal
group and 6·4 Ilg. and 58'9% in the patients.
These results, when subjected to statistical analysis, show
the following:
1. A very highly significant decrease in the total oestrogen
level per 24-hour specimen of urine in the coronary patient
when compared with the normal European group
(p = < 0'(05).
2. A very highly significant decrease in the absolute
oestradiol level (P = < O· (05) and a very highly significant
decreased percentage of oestradiol in the coronary group
(p = < 0'(05).
3. A very highly significant decrea e in the absolute
oestrone level (P = < 0'(05) and a statistically ignificant
decreased percentage in the coronary group (0,01 < p
< 0,025).
4. 0 significant differences in the ab olute oe triol
values in the 2 groups but a very highly ignificant increased
percentage of oestriol was found in the coronary group
(P = < 0'(05).
When the values obtained by u in the group of European
subjects of a mean age of 55 are cOJIlpared with the values
previously obtained by us in Europeans of a younger age
group (mean 31 years) we find that the total oestrogen,
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absolute oestradiol, oestrone and oestriol levels are statistically
higher in the former group. No significant differences were
observed in the percentage of oestradiol. whilst the oestrone
percentage was statistically lower and the oestriol percentage
significantly higher in the older age group.
DISCUSSION
The oestrogenic steroids are oestradiol, oestrone and
oestriol. The oestradiol fraction may be regarded as the true
oestrogenic hormone and the.oestrone and oestriol fractions as
breakdown products. Oestradiol and oestrone are inter-
convertible and both these steroids can be excreted as oestriol
(the relatively inert fraction). Alpha oestradiol is approxi-
mately 12 times more potent than oestrone and at least 80 times
more potent than oestriol.
Our results show that not only is the total urinary oestrogen
level lower in the myocardial infarction group but that the
potent oestradiol fraction is significantly lower (both relative
and absolute) in this group and the inert fraction oestriol is
significantly higher.
Bauld et aJ.II carried out a preliminary investigation in the
metabolism of oestrogen in men with myocardial Wfarction.
The technique for oestrogen determination was the same as
used by us: 400 ~g. oestradiol 17 f3 in oil were injected
intramuscularly in a control group of normal men and in a
group of male subjects who had experienced a previous
myocardial infarction. The total amount of oestrogen ex-
creted after the injection was similar in the two groups but
there was a marked difference in the relative proportions of
oestriol and oestrone. The urinary oestriol: oestrone ratio
was significantly higher in the· infarction group than in the
control group. These findings were unrelated to age or to the
interval after the infarction. The findings of Bauld and his
co-workers suggest a disturbed metabolism of oestrogen in
those who have had a previous myocardial infarction.
If we compare the ratio of oestriol to oestrone in the two
groups studied by us, we find in the coronary artery~
group a ratio of 1,7,: 1 and in the control group a ratIo of
O' 94 : 1. These findings substantiate those of Bauld et aJ.
When we compare the ratio of the most potent fraction
oestradiol to the least active fraction oestriol a ratio of O' 11 is
obtained in the coronary group as against a ratio of O' 36 in
the control group. Table III shows the ratio of oestradiol to
oestriol obtained by us in a group of young Bantu urban
TABLE m. RATIO OF OESTRADIOL TO OESTRIOL IN URBANIZED BANTU
AND EUROPEAN MALE SUBJECTS (MEAN AGE 31 YEARS), IN NORMAL
MALE EUROPEANS (MEAN AGE 55), AND .IN MALE roRONARY PATIENTS
. (MEAN AGE 57)
Bantu I European I European ICoronary Group
(mean age 31) I (mean age 31) (mean age 55) I (mean age 57)
0·71 1 0·43 I 0·36 I 0·11
males and young normal European male subjects compared
with the ratios obtained in this investigation. These findings
show that the metabolism of oestrogens in patients suffering
from coronaiy artery disease differs markedly from that
found in young healthy subjects who are relatively immune
from coronary occlusion.
The metabolism in the coronary group seems to be markedly
acCelerated, yielding a much higher percentage of oestriol ~th
a consequent alteration of the ratio of the active to the m-
active fractions. In the Bantu, where the incidence of coronary
artery disease is very low, a retarded breakdown of oestradiol
is found, and in normal European subjects the metabolism
is intermediate between that of the Bantu and the diseased
group.
Marmosston et aJ.,30 using a biological technique for
oestrogen determination, compared urinary oestrogen levels
in postmenopausal women with and without evidence of
myocardial infarction: 55% of the women in the control
group excreted O' 501'g. or higher oestradiol as compared
with 22 %in the infarcted group. The control group excreted
O' 516 ~g. equivalents of oestradiol as against O' 244 ~g. in the
myocardial infarction group. These findings, too, suggest an
altered metabolism of oestrogen in coronary atherosclerosis
and they confirm our findings.
Stamler et al.,aI in an interim report on the effects of
oestrogen therapy in males with a history of a previous single
myocardial infarction, show that in a placebo-treated group of
26 patients under treatment for 2 months or longer a second
infarction occurred in 6, with 3 fatalities, whilst in 39 subjects
under oestrogen therapy for a similar period no recurrences
occurred. Despite the short duration of treatment and the
small numbers treated, it was felt that continuation and ex-
pansion of this investigation was warranted.
Our present together with our previous findings, when
taken in conjunction with available experimental and clinical
evidence, tend to support the thesis that the gonadal steroid-
play an important role in the aetiology of coronary atheros
genesis.
The different patterns of~etabolism of oestrogens in the
Bantu, when compared with the myocardial group, con- -
ceivably plays an important role in the almost non-existence
of coronary thrombosis in the Bantu. Many factors could
conceivably be responsible for the altered hormonal pattern.
and it is even possible that the type of diet consumed by them
directly or indirectly influences their endocrine system and
may in part be responsible for it; in fact, unpublished work
carried out in our laboratories seems to suggest that European
subjects when habituated to the 'Bantu type of diet' show an
oestrogen pattern very similar to that of the Bantu.
The role played by oestrogens in the prevention and therapy
of coronary artery disease needs further intensive study, but
the comparative immunity of premenopausal women to
coronary thrombosis, the different sex inc~dence, and the
rarity of coronary thrombosis in the Bantu. suggest that the
gonadal steroids may be of vital significance in the develop-
ment of coronary atherosclerosis.
SUMMARY
1. Experimental and clinical evidence suggesting that oes-
trogens play a role in coronary atherosclerosis are reviewed.
2. Urinary oestrogen levels in 20 normal European middle-
aged male subjects and 23 European middle-aged hospitalized
subjects suffering from a recent myocardial infarction were
determined.
3. Highly significant decreases in the total oestrogen level
were found in the myocardial infarcted group.
4. Decreased absolute and relative oestradiol and oestrone
levels and a highly significant increased relative level of
oestriol were found in the coronary group.
5. It was suggested that the metabolism of oestrogens is
accelerated in the coronary group, that a retarded breakdown
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of oestradiol is found in the Bantu, whilst the normal Euro-
pean occupies an intermediate position.
6. The possible role played by a particular diet on oestrogen
n:etabolism is discussed.
7. The suggestion is made that the gonadal steroids are
important in the development of coronary atherosclerosis.
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LOCKED TWINS
F. E. HOFMEYR. M.B., CH.B., D.P.H. AND J. P. Roux, M.B., CH.B., M.R.C.O.G., Cape Town
Locking of twins is a very rare complication, said to occur
about once in every 90,000 deliveries and in 1 of every
1,000 cases of multiple pregnancy. Various forms of locking
are described, but some of these are more accurately referred
to as 'collision' of twins, e.g. when both heads present and
become jammed at the brim and/or in the cavity of the
pelvis. Reviewing the literature, we have fgund references
to and reportS on 12 cases of this variety recorded to date.
Locking or collision, where one foetus presents by the vertex
and the other lies transversely, is even less common, only
4 cases having been reported. The rarest fonn of obstruction
occurs where both present by the breech, and of this variety
3 cases are recorded in the literature. By far the commonest
variety appears to be true 'chin-to-ehin' locking, where
the first foetus presents as a breech and its aftercoming
head is held up by that of the 2nd twin having come to lie
below it. Of this type of locking, we have been able to
obtain details of 27 cases, and reference is made by McLin-
tock1 to a further 7, the details of which are unfortunately
not available to us.
In studying the reports of cases of the latter variety of
locking (breech and vertex), we were impressed by the
striking similarity of the circumstances under which many
of the authors, particularly amongst the earlier ones, were
called to these labours. Only too often did they arrive to
find the first baby born by the breech as far as the umbilicus
and already lifeless. How they made the diagnosis of locking
and, nothing daunted, variously set about the delivery,
makes fascinating reading and, the truly remarkable salvage
rates for the second twin, speak volumes for the dexterity
of past generations of obstetricians. However, with improve-
ment in antenatal care and the more universal availability
thereof to expectant mothers, X-ray diagnosis of twin preg-
nancy and hospitalization for delivery under supervision
of experienced resident obstetrical staff, it is evident from
the more recent publications that locking, or the possibility
thereof, is now more frequently diagnosed before the breech
of the first baby has been born so far as to entail its irre-
vocable loss.· Timely intervention by manipulation or Caesa-
rean section has enabled several recent authors to report
highly gratifying cases where both infants survived. We
have been fortunate enough to have recently delivered
locked twins alive by Caesarean section in a patient of our
own, where the operation was carried out for indications
quite unrelated to the locking. This complication, however,
became apparent only during the abdominal delivery.
Whereas our survey of the literature has made us humbly
aware of the fact that this unique experience of having
practically completed the ideal treatment of twin locking
at the time of making the diagnosis, has not been the good
fortune of any of the previous authors on the subject, we
have thought fit to publish a report of our own case. More-
over, there were several features amongst the pre-operative
clinical findings which, in retrospect, fit in rather strikingly
with the ultimate finding of locking, and which (on close
scruitiny of previous case records) have been proved not
dissimilar from the findings therein reported at the stage
where locking had not yet been diagnosed.
EastmanS remarks that the condition of locked twins
has not been encountered once among 950 cases of twins
in 75,000 deliveries at Johns Hopkins Hospital. If a man
of his experience (not forgetting Smellie1) has never met
with this complication, it is most unlikely that many readers
of this communication will do so. However, should our
observations stimulate enough interest to occasion the
taking of a few more intrapartum X-rays to exclude locking,
where the possibility suggests itself at an early and favourable
stage, the publication of this paper will have been justified.
Moreover, we hope that our review of the literature and
list of references will be as useful to future authors as we
have found that of Lawrence. S
Case Report
A primigraVida, aged 21, was first seen at the 22nd week of her
pregnancy. Both her own and her husband's mothers bad had
twins. She attended regularly for antenatal examinations. at
monthly intervals until the 30th week, and thereafter fortnightly.
Weight gain, blood pressure and urine were normal at all visits,
and oedema absent. The uterus was found throughout to be very
tense and rather tender; and at no time was it possible to make
out the lie of the foetus. The progressive enlargement of the
fundus was never in excess of what was expected for the dates,
and foetal heart tones were heard on the right side below the
umbilicus. All was well until the 36th week. when the patient
bad a small painless antepartum haemorrhage and her blood
